The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia
- 1National Clinical Research Center for Mental Disorders, and Department of Psychiatry, The Second Xiangya Hospital of Central South University; National Technology Institute on Mental Disorders; Hunan Key Laboratory of Psychiatry and Mental Health, Changsha, China
- 2Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China
A corrigendum on
The association between cognitive deficits and clinical characteristic in first-episode drug naïve patients with schizophrenia
by Peng, X. -J., Hei, G. -R., Yang, Y., Liu, C. -C., Xiao, J. -M., Long, Y. -J., Huang, J., Zhao, J. -P., and Wu, R. -R. (2021). Front. Psychiatry 12:638773. doi: 10.3389/fpsyt.2021.638773
In the published article, there was an error in Trial Registration. Instead of “NCT03451734. Registered March 2, 2018 (retrospectively registered),” it should be “NCT02880462. Registered August 26, 2016.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: cognitive impairment, first episode drug-naïve schizophrenia, MCCB, correlation analysis, positive and negative symptoms
Citation: Peng X-J, Hei G-R, Yang Y, Liu C-C, Xiao J-M, Long Y-J, Huang J, Zhao J-P and Wu R-R (2022) Corrigendum: The association between cognitive deficits and clinical characteristic in first-episode drug naïve patients with schizophrenia. Front. Psychiatry 13:1094791. doi: 10.3389/fpsyt.2022.1094791
Received: 10 November 2022; Accepted: 08 December 2022;
Published: 19 December 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Peng, Hei, Yang, Liu, Xiao, Long, Huang, Zhao and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ren-Rong Wu, wurenrong@csu.edu.cn
†Author contributed equally to this work